Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 20, 2013 09:25 ET | Source: EDAP TMS S.A.

EDAP's Ablatherm-HIFU Demonstrates Long Term Efficacy, Durability and Reproducibility With Prospective Fourteen -Year Study

LYON, France, May 20, 2013 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today new long term data demonstrating high rates of both...
May 20, 2013 08:30 ET | Source: Nuvilex, Inc.

Nuvilex, Inc. and Celgene, Corp. Can Both Replace Eli Lilly's Cancer Drug Gemzar

NEW YORK, NY--(Marketwired - May 20, 2013) - The race is on, and patients with advanced stage, inoperable pancreatic cancer will be the recipients of the winner's treatment. Two biotechnology...
May 20, 2013 08:30 ET | Source: Dehaier Medical Systems Limited

Dehaier Medical Signs a Strategic Cooperation Agreement With WideMed

BEIJING, May 20, 2013 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical...
May 20, 2013 08:05 ET | Source: Given Imaging Ltd.

Given Imaging Announces New Data Confirming SmartPill(R) Improves Diagnosis and Clinical Management of Patients With Motility Issues

ORLANDO, Fla., May 20, 2013 (GLOBE NEWSWIRE) -- Given Imaging Ltd, (Nasdaq:GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced several studies confirming an...
May 20, 2013 07:30 ET | Source: Zogenix

Zogenix and Battelle to Present Positive, New Data Demonstrating Value of Needle-Free Injection for Biologics

SAN DIEGO and COLUMBUS, Ohio, May 20, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX) and Battelle Memorial Institute today announced new data supporting the value of the DosePro®...
May 20, 2013 00:33 ET | Source: Immune Pharmaceuticals Inc

EpiCept Reports First Quarter 2013 Operating and Financial Results

PRELIMINARY PROXY STATEMENT FOR MERGER FILED WITH SEC TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX:...
May 18, 2013 12:00 ET | Source: H. Lundbeck A/S

Kliniske fase III-data om vortioxetine viser signifikant forbedring af symptomer på depression

København, 2013-05-18 18:00 CEST (GLOBE NEWSWIRE) -- Kliniske fase III-data om vortioxetine viser signifikant forbedring af symptomer på depression Takeda og Lundbeck præsenterer resultater fra...
May 18, 2013 12:00 ET | Source: H. Lundbeck A/S

Vortioxetine clinical phase III data show significant improvement in symptoms of major depression

Vortioxetine clinical phase III data show significant improvement in symptoms of major depression Takeda and Lundbeck present results from pivotal phase III clinical trials with vortioxetine,...
May 17, 2013 14:48 ET | Source: Pomerantz LLP

Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Delcath Systems, Inc. of Class Action Lawsuit and Upcoming Deadline -- DCTH

NEW YORK, May 17, 2013 (GLOBE NEWSWIRE) -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action lawsuit against Delcath Systems, Inc. ("Delcath" or the "Company")...
May 17, 2013 14:34 ET | Source: Pomerantz LLP

Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AVEO

NEW YORK, May 17, 2013 (GLOBE NEWSWIRE) -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action lawsuit against Aveo Pharmaceuticals, Inc. ("Aveo" or the "Company")...
May 17, 2013 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio Sponsors 28th Annual AIDS Walk New York as Co-Chair Advocate

MEDFORD, N.Y., May 17, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today announced that the Company is a proud...
May 17, 2013 01:30 ET | Source: Mauna Kea Technologies

Mauna Kea Technologies Announces Strongest Scientific Exposure Ever With More Than 40 Communications on Cellvizio(R) at Digestive Disease Week 2013

PARIS--(Marketwired - May 17, 2013) - Mauna Kea Technologies (EURONEXT PARIS: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, today...
May 16, 2013 16:05 ET | Source: Vascular Solutions, Inc.

Vascular Solutions Files Patent Infringement Complaint Against Boston Scientific

MINNEAPOLIS, May 16, 2013 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) announced today that it has filed a patent infringement complaint in the U.S. District Court for the District of...
May 16, 2013 09:00 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals Announces $20 Million Underwritten Offering

BERKELEY HEIGHTS, N.J., May 16, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), today announced the pricing of the underwritten offering...
May 16, 2013 08:50 ET | Source: Chembio Diagnostics, Inc.

Chembio Enters Into Six-Month Follow-On Contract With CDC Contractor for Development of Rapid, Point-of-Care Influenza Immunity Test

MEDFORD, N.Y., May 16, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, announces that the Company has...
May 16, 2013 07:30 ET | Source: Lisata Therapeutics

NeoStem Announces Geographic Expansion of Intellectual Property Coverage of Cardiovascular Asset AMR-001

NEW YORK, May 16, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy market, today announced the geographic expansion of...
May 16, 2013 07:30 ET | Source: EDAP TMS S.A.

EDAP Reports 23% Increase in First Quarter 2013 Revenues

First quarter 2013 revenue rose 23% to EUR 5.9 million (USD 7.8 million) Continuing US investments in both FDA regulatory process and US operations Great momentum and success achieved at...
May 16, 2013 07:00 ET | Source: Curis, Inc.

Curis Announces Presentation of CUDC-427 and Erivedge(R) Clinical Results at ASCO Annual Meeting

LEXINGTON, Mass., May 16, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop next generation targeted drug candidates for cancer treatment, today...
May 16, 2013 06:00 ET | Source: Vital Therapies

Vital Therapies, Inc. Adds Two New Board Members

SAN DIEGO, CA--(Marketwired - May 16, 2013) - Vital Therapies, Inc., a development stage biotechnology company focused on developing the first bio-artificial liver for life-threatening acute liver...
May 16, 2013 01:38 ET | Source: Bavarian Nordic A/S

Bavarian Nordic - Interim Financial Report for the Period 1 January to 31 March 2013

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} KVISTGAARD, Denmark, May 16, 2013 - Bavarian Nordic...
May 16, 2013 01:30 ET | Source: DBV Technologies S.A.

DBV Technologies et Stallergenes s'associent pour développer des traitements innovants contre les allergies respiratoires

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Stallergenes et DBV Technologies s'associent pour...
May 15, 2013 17:00 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics, Inc. Reports First Quarter 2013 Financial Results

SOUTH SAN FRANCISCO, Calif., May 15, 2013 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCQB:TLON), today reported financial results for the three months ended March 31, 2013. Corporate...
May 15, 2013 16:15 ET | Source: Arbutus Biopharma Corporation

Tekmira Presents LNP Technology Innovations at Scientific Symposium

VANCOUVER, British Columbia, May 15, 2013 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that...
May 15, 2013 16:01 ET | Source: Bio Green Med Solution, Inc.

Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock

BERKELEY HEIGHTS, N.J., May 15, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), today announced that it is offering to sell, subject to...
May 15, 2013 14:38 ET | Source: Aeolus Pharmaceuticals

Aeolus Pharmaceuticals Announces Second Quarter Fiscal Year 2013 Financial Results

MISSION VIEJO, CA--(Marketwired - May 15, 2013) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel...
May 15, 2013 09:30 ET | Source: Capstone Therapeutics

Capstone Therapeutics Will Provide an Operating Update and Announces First Quarter 2013 Financial Results

TEMPE, Ariz., May 15, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), today will hold a conference call and webcast to provide an operating update and announced financial...
May 15, 2013 08:30 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Reports First Quarter 2013 Results and Operating Highlights

SEATTLE, WA--(Marketwired - May 15, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), the Breast Health Company™, today announced its first quarter 2013 financial results and corporate...
May 15, 2013 07:01 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Prices $35.0 Million Public Offering of Common Stock

WIXOM, Mich., May 15, 2013 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease...
May 15, 2013 05:31 ET | Source: RaySearch Laboratories AB

RaySearch erhåller amerikanskt marknadsgodkännande för RayStation® 3.5

I mars tillkännagav RaySearch Laboratories AB (publ.) att version 3.5 av RaySearchs dosplaneringssystem RayStation® hade släppts förkliniskt bruk. RaySearch har nu erhållit regulatoriskt...
May 15, 2013 05:31 ET | Source: RaySearch Laboratories AB

RaySearch receives 510(k) clearance for RayStation® 3.5

In March RaySearch Laboratories AB announced that version 3.5 of RaySearch's RayStation® treatment planning system had been released for clinical use. RaySearch has now received 510(k) clearance from...
May 15, 2013 02:35 ET | Source: Zealand Pharma A/S

Zealand Pharma A/S ─ Interim report for Q1 2013 (un-audited)

Copenhagen, 2013-05-15 08:35 CEST (GLOBE NEWSWIRE) -- Company Announcement No. 14/2013 ─ Fully in line with expectations, net...
May 15, 2013 02:35 ET | Source: Zealand Pharma A/S

Zealand Pharma A/S ─ Delårsrapport for 1. kvartal 2013 (ikke revideret)

København, 2013-05-15 08:35 CEST (GLOBE NEWSWIRE) -- Selskabsmeddelelse Nr. 14/2013 ─ Helt som forventet blev...
May 14, 2013 16:05 ET | Source: Cesca Therapeutics Inc.

ThermoGenesis Reports Third Quarter Fiscal 2013 Results

RANCHO CORDOVA, Calif., May 14, 2013 (GLOBE NEWSWIRE) -- ThermoGenesis Corp. (Nasdaq:KOOL), a leading supplier of enabling technologies for the processing, storage of stem cells and other biological...
May 14, 2013 16:01 ET | Source: Rockwell Medical, Inc.

Rockwell Medical Announces Proposed Public Offering of Common Stock

WIXOM, Mich., May 14, 2013 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease...
May 14, 2013 16:00 ET | Source: Arbutus Biopharma Corporation

Tekmira Provides Corporate Update and Announces First Quarter 2013 Results

VANCOUVER, British Columbia, May 14, 2013 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced...
May 14, 2013 09:51 ET | Source: Imaging Diagnostic Systems, Inc.

IDSI Announces Ministry of Health Approval in Kuwait to Distribute CTLM(R), the innovative 3D Laser Breast Imaging System

FORT LAUDERDALE, Fla., May 14, 2013 (GLOBE NEWSWIRE) -- Imaging Diagnostic Systems, Inc. (OTC:IMDS), a pioneer in laser breast imaging, announced today that it has received approval from the Ministry...
May 14, 2013 09:05 ET | Source: Chembio Diagnostics, Inc.

Chembio's DPP(R) HIV-Syphilis Multiplex Test Demonstrates 100% Sensitivity and Specificity in Evaluation by Mexico's Institute of Epidemiological Diagnosis and Reference

MEDFORD, N.Y., May 14, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, announces receipt of an evaluation report...
May 14, 2013 09:00 ET | Source: EDAP TMS S.A.

EDAP's Ablatherm-HIFU Receives Two Best Poster Awards at 2013 American Urological Association Annual Meeting

Four Scientific Sessions Highlighted HIFU for Treatment of Prostate Cancer HIFU Featured in Plenary Lecture and Two Moderated Posters at Engineering and Urology Society Meeting Significant...
May 14, 2013 08:30 ET | Source: Plandai Biotechnology, Inc.

Plandai Biotechnology, Inc. New Products to Hit the Market With Higher Absorption Rate

NEW YORK, NY--(Marketwired - May 14, 2013) - In a series of articles, Stock House Group, a research and content development investment relations firm, will lay out Plandaí Biotechnology,...
May 14, 2013 08:30 ET | Source: Atossa Genetics, Inc.

Atossa Genetics to Present at the Sachs Associates Cancer Bio Partnering Forum and Participate on the Cancer Tech Panel

SEATTLE, WA--(Marketwired - May 14, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Dr. Steven Quay, Chairman, CEO & President, will speak...
May 14, 2013 08:30 ET | Source: American CryoStem Corp.

American CryoStem to Collaborate With Rutgers University on Adipose-Derived Stem Cell Research

EATONTOWN, N.J., May 14, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based and cellular...
May 14, 2013 07:30 ET | Source: LipoScience, Inc.

LipoScience to Present at UBS Global Healthcare Services Conference

RALEIGH, N.C., May 14, 2013 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that Richard Brajer, President and Chief Executive Officer, and Lucy Martindale, Executive Vice...
May 14, 2013 07:30 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs and Incuron Announce US and European Patent Allowances for Curaxins

BUFFALO, N.Y., May 14, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between the Company and Bioprocess Capital Ventures, today announced the receipt...
May 14, 2013 07:00 ET | Source: Gentium S.p.A.

Gentium Reports First Quarter Financial Results

Defibrotide usage increased by 32% to EUR 6.49 million (US$ 8.31 million). Product sales of EUR 7.54 million (US$ 9.65 million) for the three month period ended March 31, 2013, recording an...
May 14, 2013 06:05 ET | Source: IntelGenx Corp.

IntelGenx Reports Q1, 2013 Results and Provides Operational Update

SAINT LAURENT, Quebec, May 14, 2013 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the "Company") today announced financial results for the quarter ended March 31, 2013 and...
May 14, 2013 05:15 ET | Source: Nuwellis, Inc.

Sunshine Heart Announces Corporate Updates and First Quarter 2013 Financial Results

EDEN PRAIRIE, Minn., May 14, 2013 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) today announced corporate updates and financial results for the first quarter ended March 31, 2013. First...
May 14, 2013 04:00 ET | Source: PartnerTech AB

PartnerTech and Cavidi develop unique instrument for HIV-test

PartnerTech AB and Cavidi AB, a company developing innovative solutions for the health and life science sector, have signed a framework agreement regarding the development of an instrument for HIV...
May 14, 2013 04:00 ET | Source: PartnerTech AB

PartnerTech och Cavidi utvecklar unikt instrument för HIV-test

PartnerTech AB och Cavidi AB, ett företag som utvecklar innovativa lösningar inom hälsovårds och life science sektorn, har tecknat ett samarbetsavtal avseende utveckling av instrument för HIV-test....
May 14, 2013 02:30 ET | Source: VALNEVA

Merger between Intercell and Vivalis planned to complete on May 28, 2013

Merger between Intercell and Vivalis planned to complete on May 28, 2013 Relevant documents filed with the Commercial Court of Lyon Vienna (Austria), Nantes (France) May 14, 2013 - Intercell AG...
May 14, 2013 02:30 ET | Source: VALNEVA

Fusion effective entre Intercell et Vivalis prévue pour le 28 mai 2013

Fusion effective entre Intercell et Vivalis prévue pour le 28 mai 2013 Documents déposés auprès du Tribunal de Commerce de Lyon Vienne (Autriche), Nantes (France), le 14 mai 2013 - Intercell AG...